Loading...

Diffusion Pharmaceuticals (NASDAQ:DFFN) Creates a Treatment to Improve Oxygenation

Print Friendly, PDF & Email

Robert Cobuzzi is the new CEO at Diffusion Pharmaceuticals Inc. He was a company director since January 2020. He is currently adviser to the Mitochondrial Disease Frontier Program at the Children’s Hospital of Philadelphia and Chairman of Sunstone Life Science Venture’s Business Development Board. From 2005 until 2018, he […]